Otsuka Pharmaceutical – Walk-In Interviews on 23rd Sep’ 2023

Otsuka Pharmaceutical India Private Limited (OPI) is a Joint Venture between Otsuka Pharmaceutical Factory, Inc., Japan and Mitsui & Co. Ltd., Japan, for Infusion Business in India and Emerging Markets. We primarily manufacture & market products across multiple markets and therapeutic segments. Being a leader in intravenous nutrition products, we are committed to being the best partner of patients and healthcare professionals in the field of clinical nutrition..

Otsuka Pharmaceutical Walk-in Interview

  • Qualification: B.Pharm, M.Pharm
  • Experience : 02-07+years
  • Department: Regulatory Affairs
  • Job Location: Ahmedabad
  • Role: Process Incharge
  • Salary: 3-6 Lacs P.A.
  • No. of Openings: 03

Time and Venue:

23 September , 9.00 AM – 2.00 PM

Otsuka Pharmaceutical India Pvt. Ltd., 21st Floor, B Block, Westgate, near YMCA Club, SG Highway, Ahmedabad-380015, Gujarat. Tele. – 079-66216000

Contact – Himanshu ( 7984556557 )

Job description:

Role & responsibilities:

  • Dossier preparation/review as per country specific guideline/CTD guideline
  • Timely query response submission to Distributor/ MOH
  • Review of documents for its correctness and compliance with respective regulatory guidelines (as per country requirement)
  • Preparation, review & release of artworks & sales order as per country approval
  • Variation documents preparation and filing as per country requirements
  • Timely dispatch of tender documents to country/parties as per deadline

Preferred candidate profile:

  • Should be able to review & interpret the requirement as per country specific/ tender guideline
  • Should be able to review various plant documents for dossier preparation like Process validation, Stability study, PDR, Method validation, SOP, Drug Master file, BMR, APR etc.
  • Should be able to handle team of two members
  • Should be able to communicate with relevant functions for procurement of required regulatory documents
  • Should be able to communicate with relevant counter part at country
  • Preferred Immediate joiners

Tags:

Leave a Comment